Risk of gastric cancer, gastrointestinal cancers and other cancers: a comparison of treatment with pantoprazole and other proton pump inhibitors

Summary Background Proton pump inhibitors (PPIs) have been shown to be carcinogenic in rodent studies. Aim As part of a long‐term post‐marketing surveillance study requested by the US Food and Drug Administration, to compare incidence rates of gastric and other cancers after sustained exposures to p...

Ausführliche Beschreibung